NO20031693L - New anticholinergic agents which may be used as medicaments and methods for their preparation - Google Patents
New anticholinergic agents which may be used as medicaments and methods for their preparationInfo
- Publication number
- NO20031693L NO20031693L NO20031693A NO20031693A NO20031693L NO 20031693 L NO20031693 L NO 20031693L NO 20031693 A NO20031693 A NO 20031693A NO 20031693 A NO20031693 A NO 20031693A NO 20031693 L NO20031693 L NO 20031693L
- Authority
- NO
- Norway
- Prior art keywords
- medicaments
- preparation
- methods
- anticholinergic agents
- new anticholinergic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10050994A DE10050994A1 (en) | 2000-10-14 | 2000-10-14 | New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease |
PCT/EP2001/011226 WO2002032899A1 (en) | 2000-10-14 | 2001-09-28 | Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20031693D0 NO20031693D0 (en) | 2003-04-11 |
NO20031693L true NO20031693L (en) | 2003-05-28 |
NO328207B1 NO328207B1 (en) | 2010-01-11 |
Family
ID=7659808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20031693A NO328207B1 (en) | 2000-10-14 | 2003-04-11 | New anticholinergic agents which may be used as medicaments and methods for their preparation |
Country Status (38)
Country | Link |
---|---|
EP (2) | EP1325001B1 (en) |
JP (2) | JP4109106B2 (en) |
KR (1) | KR100830359B1 (en) |
CN (1) | CN1275962C (en) |
AR (1) | AR035589A1 (en) |
AT (1) | ATE259805T1 (en) |
AU (2) | AU1397502A (en) |
BG (1) | BG66225B1 (en) |
BR (1) | BR0114635A (en) |
CA (1) | CA2425557C (en) |
DE (2) | DE10050994A1 (en) |
DK (1) | DK1325001T3 (en) |
EA (1) | EA005816B1 (en) |
EC (1) | ECSP034542A (en) |
EE (1) | EE05179B1 (en) |
ES (1) | ES2215147T3 (en) |
HK (1) | HK1060566A1 (en) |
HR (1) | HRP20030278B1 (en) |
HU (1) | HUP0301203A3 (en) |
IL (2) | IL155334A0 (en) |
ME (1) | MEP39908A (en) |
MX (1) | MXPA03003160A (en) |
MY (1) | MY127144A (en) |
NO (1) | NO328207B1 (en) |
NZ (1) | NZ525836A (en) |
PE (1) | PE20020433A1 (en) |
PL (1) | PL207311B1 (en) |
PT (1) | PT1325001E (en) |
RS (1) | RS50464B (en) |
SA (1) | SA01220414B1 (en) |
SI (1) | SI1325001T1 (en) |
SK (1) | SK287138B6 (en) |
TR (1) | TR200400376T4 (en) |
TW (1) | TWI306098B (en) |
UA (1) | UA73804C2 (en) |
UY (1) | UY26958A1 (en) |
WO (1) | WO2002032899A1 (en) |
ZA (1) | ZA200302914B (en) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10200943A1 (en) | 2002-01-12 | 2003-07-24 | Boehringer Ingelheim Pharma | Process for the preparation of scopine esters |
US7405224B2 (en) | 2002-01-31 | 2008-07-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions |
DE10203753A1 (en) * | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | New xanthene carboxylic acid esters, processes for their preparation and their use as medicines |
DE10216429A1 (en) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma | Synergistic medicaments for treating inflammatory or obstructive respiratory tract diseases, containing quaternized scopine ester anticholinergic agent and steroid, e.g. budesonide |
US7417051B2 (en) | 2002-04-12 | 2008-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising betamimetics and a novel anticholinergic |
JP2005529111A (en) * | 2002-04-12 | 2005-09-29 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | Drugs containing beta mimetics and novel anticholinesterase agents |
DE10256317A1 (en) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma | Synergistic medicaments used for treating inflammaSynergistic medicaments used for treating inflammatory or obstructive respiratory tract diseases, cotory or obstructive respiratory tract diseases, contain quaternized scopine ester anticholinergic agntain quaternized scopine ester anticholinergic agent and beta-mimetic agent e.g. salmeterol salt ent and beta-mimetic agent e.g. salmeterol salt |
US7084153B2 (en) | 2002-04-12 | 2006-08-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising steroids and a novel anticholinergic |
DE10224091A1 (en) * | 2002-05-31 | 2003-12-11 | Boehringer Ingelheim Pharma | Technical process for the production of tropenol |
DE10230751A1 (en) | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drug compositions based on new anticholinergics and EGFR kinase inhibitors |
DE10230769A1 (en) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drug compositions based on new anticholinergics and PDE-IV inhibitors |
DE10230750A1 (en) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drug compositions based on new anticholonergics and NK1 receptor antagonists |
EP1707205A2 (en) | 2002-07-09 | 2006-10-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
PL375511A1 (en) * | 2002-08-14 | 2005-11-28 | Boehringer Ingelheim Pharma Gmbh & Co.Kg | Aerosol formulation for inhalation containing an anticholinergic agent |
DE10237739A1 (en) * | 2002-08-17 | 2004-02-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalable medicament for treating inflammatory or obstructive respiratory diseases, containing synergistic combination of tropane derivative anticholinergic agent, corticosteroid and beta-mimetic agent |
US7244742B2 (en) | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
DE10317461A1 (en) | 2003-04-16 | 2004-10-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt |
US7332175B2 (en) | 2003-05-27 | 2008-02-19 | Boehringer Ingelheim International Gmbh | Long-acting drug combinations for the treatment of respiratory complaints |
DE10323966A1 (en) * | 2003-05-27 | 2004-12-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New long-acting drug combinations for the treatment of respiratory diseases |
US7273603B2 (en) * | 2003-07-11 | 2007-09-25 | Boehringer Ingelheim International Gmbh | HFC solution formulations containing an anticholinergic |
US7462367B2 (en) | 2003-07-11 | 2008-12-09 | Boehringer Ingelheim International Gmbh | Anticholinergic powder formulations for inhalation |
DE10331350A1 (en) * | 2003-07-11 | 2005-01-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalation powder useful for treating respiratory diseases comprises a 9,9-dimethyl-7-(2,2-diphenylpropionyloxy)-3-oxa-9-azatricyclononane salt and a finely divided excipient |
EP1651230B1 (en) * | 2003-07-28 | 2009-07-01 | Boehringer Ingelheim International GmbH | Medicaments for inhalation comprising steroids and a novel fluorene carboxylic acid ester |
DE602004019096D1 (en) * | 2003-07-28 | 2009-03-05 | Boehringer Ingelheim Pharma | MEDICAMENTS FOR INHALATION WITH BETAMIMETICS AND ANTICHOLINERGICUM |
EP1651208A1 (en) * | 2003-07-28 | 2006-05-03 | Boehringer Ingelheim International GmbH | Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders |
WO2005013994A1 (en) * | 2003-07-31 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising anticholinergics and a betamimetic |
EP1504756A1 (en) * | 2003-08-06 | 2005-02-09 | Kyowa Hakko Kogyo Co., Ltd | Medicament compositions comprising a heterocyclic compound and an anticholinergic |
DE10345065A1 (en) * | 2003-09-26 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation containing an anticholinergic |
WO2005067929A1 (en) * | 2004-01-09 | 2005-07-28 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions based on a scopineester and nicotinamide derivatives |
EP1718301A1 (en) * | 2004-02-20 | 2006-11-08 | Boehringer Ingelheim International GmbH | Pharmaceutical compositions based on anticholinergics and pegsunercept |
US7507745B2 (en) | 2004-02-20 | 2009-03-24 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins |
US20050186175A1 (en) * | 2004-02-20 | 2005-08-25 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins |
DE102004016179A1 (en) * | 2004-03-30 | 2005-10-20 | Boehringer Ingelheim Pharma | Compounds for the treatment of proliferative processes |
US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
DE602004020337D1 (en) * | 2004-08-11 | 2009-05-14 | Boehringer Ingelheim Pharma | Anticholinergic drugs for the treatment of urinary tract disorders |
DE102004056578A1 (en) * | 2004-11-23 | 2006-05-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhaled drugs containing a new anticholinergic, formoterol and a steroid |
WO2006087316A1 (en) * | 2005-02-16 | 2006-08-24 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions comprising anticholinergics and etiprednol |
EP1858554A2 (en) * | 2005-03-09 | 2007-11-28 | Boehringer Ingelheim International GmbH | New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors |
CA2609429A1 (en) * | 2005-05-31 | 2006-12-07 | Boehringer Ingelheim International Gmbh | Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor |
JP2008543806A (en) * | 2005-06-17 | 2008-12-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | MRPIV inhibitors for the treatment of respiratory diseases |
DE102005030733A1 (en) | 2005-07-01 | 2007-01-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drug combinations for the treatment of respiratory diseases containing long-acting beta-2 agonists and at least one other active ingredient |
PL1917253T3 (en) | 2005-08-15 | 2015-06-30 | Boehringer Ingelheim Int | Method for producing betamimetics |
EP1948164A1 (en) | 2005-10-19 | 2008-07-30 | Ranbaxy Laboratories, Ltd. | Pharmaceutical compositions of muscarinic receptor antagonists |
DE102005055961A1 (en) * | 2005-11-24 | 2007-05-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical composition containing specific concentration of quaternary ammonium anticholinergic agent, useful for treatment, by inhalation, of respiratory tract diseases |
DE102005055963A1 (en) * | 2005-11-24 | 2007-07-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation containing an anticholinergic |
DE102005055957A1 (en) * | 2005-11-24 | 2007-07-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation containing an anticholinergic |
DE502007006951D1 (en) | 2006-08-07 | 2011-05-26 | Boehringer Ingelheim Pharma | MEDICINAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES |
EP1958947A1 (en) | 2007-02-15 | 2008-08-20 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type 4 |
AP2453A (en) | 2007-03-14 | 2012-08-31 | Ranbaxy Lab Ltd | Pyrazolo(3,4-B) pyridine derivatives as phosphodiesterase inhibitors |
EP2011538B1 (en) | 2007-07-06 | 2016-02-17 | Vectura Delivery Devices Limited | Inhaler |
US20100234411A1 (en) * | 2007-07-18 | 2010-09-16 | Boehringer Ingelheim Intermational Gmbh | New Combination for the Treatment of Respiratory Diseases |
EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
EP2082767A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
EP2082768A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
EP2082766A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Blister Strip Coil Forming |
EP2082771A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
EP2082772A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
WO2010112358A2 (en) | 2009-03-31 | 2010-10-07 | Boehringer Ingelheim International Gmbh | Method for coating a surface of a component |
EP2432531B1 (en) | 2009-05-18 | 2019-03-06 | Boehringer Ingelheim International GmbH | Adapter, inhalation device and nebulizer |
GB0918450D0 (en) | 2009-10-21 | 2009-12-09 | Innovata Ltd | Composition |
JP5715640B2 (en) | 2009-11-25 | 2015-05-13 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Nebulizer |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
EP2504051B1 (en) | 2009-11-25 | 2019-09-04 | Boehringer Ingelheim International GmbH | Nebulizer |
EP2585151B1 (en) | 2010-06-24 | 2018-04-04 | Boehringer Ingelheim International GmbH | Nebulizer |
WO2012130757A1 (en) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medical device comprising a container |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2013152894A1 (en) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Atomiser with coding means |
DK2934544T3 (en) | 2012-12-21 | 2019-03-04 | Boehringer Ingelheim Vetmedica Gmbh | PHARMACEUTICAL FORMULA INCLUDING CICLESONID |
WO2014096115A1 (en) | 2012-12-21 | 2014-06-26 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide for the treatment of airway disease in horses |
EP3030298B1 (en) | 2013-08-09 | 2017-10-11 | Boehringer Ingelheim International GmbH | Nebulizer |
PL2835146T3 (en) | 2013-08-09 | 2021-04-06 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2015169428A2 (en) | 2014-05-07 | 2015-11-12 | Boehringer Ingelheim International Gmbh | Nebulizer |
AU2015257878B2 (en) | 2014-05-07 | 2019-08-08 | Boehringer Ingelheim International Gmbh | Container, nebulizer and use |
JP6559157B2 (en) | 2014-05-07 | 2019-08-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Nebulizer |
PL3157522T3 (en) | 2014-06-18 | 2020-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses |
DK3344627T5 (en) * | 2015-09-04 | 2021-08-30 | Janssen Pharmaceutica Nv | THERAPEUTIC COMPOUNDS FOR PAIN AND ITS SYNTHESIS |
CN113292574B (en) * | 2020-02-21 | 2022-05-03 | 四川大学 | Chiral polycyclic tropane compounds, preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4003270A1 (en) * | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | NEW SPEED GASES AND THEIR USE IN MEDICINE PREPARATIONS |
DE4108393A1 (en) * | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS |
-
2000
- 2000-10-14 DE DE10050994A patent/DE10050994A1/en not_active Withdrawn
-
2001
- 2001-09-28 DE DE50101524T patent/DE50101524D1/en not_active Expired - Lifetime
- 2001-09-28 HU HU0301203A patent/HUP0301203A3/en unknown
- 2001-09-28 ES ES01982374T patent/ES2215147T3/en not_active Expired - Lifetime
- 2001-09-28 KR KR1020037005256A patent/KR100830359B1/en not_active IP Right Cessation
- 2001-09-28 TR TR2004/00376T patent/TR200400376T4/en unknown
- 2001-09-28 JP JP2002536281A patent/JP4109106B2/en not_active Expired - Lifetime
- 2001-09-28 MX MXPA03003160A patent/MXPA03003160A/en active IP Right Grant
- 2001-09-28 UA UA2003054186A patent/UA73804C2/en unknown
- 2001-09-28 CN CNB018171443A patent/CN1275962C/en not_active Expired - Lifetime
- 2001-09-28 AT AT01982374T patent/ATE259805T1/en active
- 2001-09-28 EA EA200300459A patent/EA005816B1/en not_active IP Right Cessation
- 2001-09-28 EP EP01982374A patent/EP1325001B1/en not_active Expired - Lifetime
- 2001-09-28 NZ NZ525836A patent/NZ525836A/en not_active IP Right Cessation
- 2001-09-28 PL PL360673A patent/PL207311B1/en not_active IP Right Cessation
- 2001-09-28 RS YUP-295/03A patent/RS50464B/en unknown
- 2001-09-28 CA CA002425557A patent/CA2425557C/en not_active Expired - Lifetime
- 2001-09-28 EP EP03023933A patent/EP1382606A3/en not_active Withdrawn
- 2001-09-28 SK SK435-2003A patent/SK287138B6/en not_active IP Right Cessation
- 2001-09-28 BR BR0114635-1A patent/BR0114635A/en not_active Expired - Fee Related
- 2001-09-28 AU AU1397502A patent/AU1397502A/en active Pending
- 2001-09-28 AU AU2002213975A patent/AU2002213975B2/en not_active Expired
- 2001-09-28 DK DK01982374T patent/DK1325001T3/en active
- 2001-09-28 ME MEP-399/08A patent/MEP39908A/en unknown
- 2001-09-28 IL IL15533401A patent/IL155334A0/en active IP Right Grant
- 2001-09-28 PT PT01982374T patent/PT1325001E/en unknown
- 2001-09-28 SI SI200130085T patent/SI1325001T1/en unknown
- 2001-09-28 EE EEP200300151A patent/EE05179B1/en not_active IP Right Cessation
- 2001-09-28 WO PCT/EP2001/011226 patent/WO2002032899A1/en active IP Right Grant
- 2001-10-02 SA SA01220414A patent/SA01220414B1/en unknown
- 2001-10-10 UY UY26958A patent/UY26958A1/en not_active Application Discontinuation
- 2001-10-12 AR ARP010104785A patent/AR035589A1/en active Pending
- 2001-10-12 PE PE2001001018A patent/PE20020433A1/en not_active Application Discontinuation
- 2001-10-12 TW TW090125220A patent/TWI306098B/en not_active IP Right Cessation
- 2001-10-12 MY MYPI20014765A patent/MY127144A/en unknown
-
2003
- 2003-03-28 BG BG107688A patent/BG66225B1/en active Active
- 2003-04-07 EC EC2003004542A patent/ECSP034542A/en unknown
- 2003-04-10 IL IL155334A patent/IL155334A/en not_active IP Right Cessation
- 2003-04-11 HR HR20030278A patent/HRP20030278B1/en not_active IP Right Cessation
- 2003-04-11 ZA ZA200302914A patent/ZA200302914B/en unknown
- 2003-04-11 NO NO20031693A patent/NO328207B1/en not_active IP Right Cessation
-
2004
- 2004-05-20 HK HK04103582A patent/HK1060566A1/en not_active IP Right Cessation
-
2008
- 2008-02-14 JP JP2008033492A patent/JP2008120834A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20031693D0 (en) | New anticholinergic agents which may be used as medicaments and methods for their preparation | |
NO2023030I1 (en) | Apixaban and pharmaceutical acceptable salts thereof | |
PL401469A1 (en) | Azabicyclic derivative, method of its production, its use in medicine and derivative composition | |
NO20040072L (en) | New substituted benzimidazole dosage forms and methods for using the same | |
NO20031744L (en) | New non-imadazole compounds and pharmaceutical compositions comprising such | |
NO20025133L (en) | New, long-acting beta-mimetics, methods for their preparation and their use as drugs | |
ATE371647T1 (en) | 3-CYANOCINOLINES, 3-CYANO-1,6-NAPHTHYRIDINES AND 3-CYANO-1,7-NAPHTHYRIDINES AS PROTEIN KINASE INHIBITORS | |
DK1345937T3 (en) | Quinuclidine carbamate derivatives and their use as M3 antagonists | |
NO20030298L (en) | Novel heteroaryl derivatives and their use as pharmaceutical agents | |
NO20030418L (en) | New pharmaceutical preparation | |
DK1498413T3 (en) | 4-aminopicolinates and their use as herbicides | |
ATE464050T1 (en) | ARIPIPRAZOLE LOW HYGROSCOPY ACTIVE SUBSTANCE AND METHOD FOR THE PRODUCTION THEREOF | |
AU2002213975A1 (en) | Novel anticholinergic agents that can be used as medicaments and method for the production thereof | |
NO20030870L (en) | Bicyclic heterocycles, drugs containing them, their use and the method of preparation thereof | |
NO20025357L (en) | Anthranylamides and their use as drugs | |
DE60125945D1 (en) | NOSE RINSE AND ITS OUTLET | |
NO20035328D0 (en) | New compounds and preparations as catheps inhibitors | |
NO20025504L (en) | New thiochromane derivatives and their use as thrombin inhibitors | |
NO20030156L (en) | Pharmaceutical compositions and methods for their use | |
NO20016404D0 (en) | Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them | |
FI20000194A0 (en) | The method of trading | |
NO20030822D0 (en) | New compounds and methods | |
NO20031108L (en) | Pharmaceutical composition for the treatment of headache, and method for the preparation of the preparation | |
NO20024105L (en) | Memnopeptides, Methods for their Preparation and Use | |
NO20042022L (en) | Solid drug formulation containing pipiperazine urea derivative and process for preparing the formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |